Coastar Therapeutics

Recent Finacing

Pre-Series A

Recent Raise

Undisclosed

Coastar Therapeutics develops ENHEnS cell‑membrane coating technology to shield oncolytic viruses, AAV, nucleic acids, and proteins for systemic delivery, co‑developing pipelines with biotech partners and expanding R&D and production.